Sg3 Management, LLC Amgen Inc Transaction History

Sg3 Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $10.5 Million - $11.6 Million	-48,000 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$198.88 - $227.6 $3.18 Million - $3.64 Million	16,000 Added 50.0%	48,000 $10.8 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $7.47 Million - $8.29 Million	32,000 New	32,000 $7.8 Million
Q3 2017 Jan 25, 2018	SELL	$167.29 - $191.0 $418,225 - $477,500	-2,500 Closed	0 $0
Q2 2017 Jan 25, 2018	BUY	N/A	2,500	2,500 $431,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.